inside scoop
Welcome to the home of all things IDEXX inVue Dx Cellular Analyzer. Here you’ll find all sorts of exclusive and exciting stories, info, tech, and updates throughout the year.
In the coming months, you’ll be seeing:
Exciting news and details.
How the IDEXX inVue Dx analyzer can help your patients.
How a slide-free workflow will help your practice.
Use cases, seminars, webinars, and more.
When your workflow is better, everything is better.
Hear from customers who have experienced the practice-changing workflow of the IDEXX inVue Dx analyzer.
Deeper insights with IDEXX inVue Dx analyzer
Get a closer look at the reports only the IDEXX inVue Dx can provide. Blood morphology and ear cytology reports give you insights like you've never had. Download now .
You asked. We answered.
Matt Furtney, IDEXX inVue Dx Product Manager, and Kim Yore, DVM, MS, DACVIM, answer your questions about the IDEXX inVue Dx Cellular Analyzer.
How big a difference does a slide-free workflow make? You be the judge.
Check out our infographic for a side-by-side comparison. Download now .
What is the IDEXX inVue Dx analyzer?
It’s a practice-changer.
Never before could you diagnose and act on clinically important cell types with reference laboratory-level accuracy, in real time, with a slide-free workflow.
- Automated, real-time cytology and blood morphology.
- Slide-free workflow.
- Results with reference laboratory-level accuracy in under 10 minutes.
- Built and trained by IDEXX's global network of board-certified pathologists.
Forward-looking statements
This web page, and the marketing content linked from this page, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including forward-looking statements regarding the launch and potential future menu and category expansions of the IDEXX inVue DxTM Cellular Analyzer. These forward-looking statements are intended to provide management's expectation of future events as of the date of this content; are based on management's estimates, projections, beliefs and assumptions as of the date of this content; and are not guarantees of future performance. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements.
Those risks and uncertainties include, among other things, risks associated with developing and delivering new products and services, including menu expansion. The reports filed by IDEXX pursuant to U.S. securities laws (which are available from the SEC’s EDGAR database at sec.gov and via IDEXX’s website at idexx.com) also contain discussions of the risks, uncertainties and other factors that affect our business that you should carefully evaluate together with the forward-looking statements. No forward-looking statement can be guaranteed. You should not put undue reliance on any forward-looking statements, which speak only as of the date of this content. IDEXX assumes no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Any products, services, features or functionality referenced in this content that are not currently available may not be delivered on time or at all. Product roadmaps do not represent a commitment, obligation or promise to deliver any product, feature or functionality, and you should not rely on them to make your purchase decisions.